Rhythm Pharmaceuticals Correlations

RYTM Stock

USD 53.72 1.68 3.23%

The current 90-days correlation between Rhythm Pharmaceuticals and Revolution Medicines is 0.52 (i.e., Very weak diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rhythm Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rhythm Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Rhythm Pharmaceuticals Correlation With Market

Modest diversification

The correlation between Rhythm Pharmaceuticals and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.

Moving together with Rhythm Stock

0.65	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.65	CMND	Clearmind Medicine Common	Pair Corr
0.7	BA	Boeing	Pair Corr
0.66	HD	Home Depot	Pair Corr
0.65	DIS	Walt Disney	Pair Corr

Moving against Rhythm Stock

0.43	LUCD	Lucid Diagnostics	Pair Corr
0.41	PG	Procter Gamble	Pair Corr
0.34	WM	Waste Management	Pair Corr
0.6	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.49	T	ATT Inc Sell-off Trend	Pair Corr
0.34	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.34	CVX	Chevron Corp	Pair Corr

Related Correlations Analysis

	RVMD	AKRO	RNA	PTGX	STOK	QURE	RCKT	SLDB	MGTX	NUVL
RVMD		-0.29	0.3	-0.51	0.78	0.76	0.9	-0.36	-0.42	0.69	RVMD
AKRO	-0.29		0.56	0.14	-0.11	-0.43	-0.48	0.25	0.52	0.14	AKRO
RNA	0.3	0.56		0.14	0.49	0.25	0.05	-0.11	0.32	0.63	RNA
PTGX	-0.51	0.14	0.14		-0.35	-0.15	-0.58	0.4	0.5	-0.34	PTGX
STOK	0.78	-0.11	0.49	-0.35		0.79	0.73	-0.63	-0.43	0.83	STOK
QURE	0.76	-0.43	0.25	-0.15	0.79		0.79	-0.51	-0.36	0.62	QURE
RCKT	0.9	-0.48	0.05	-0.58	0.73	0.79		-0.45	-0.59	0.57	RCKT
SLDB	-0.36	0.25	-0.11	0.4	-0.63	-0.51	-0.45		0.51	-0.53	SLDB
MGTX	-0.42	0.52	0.32	0.5	-0.43	-0.36	-0.59	0.51		-0.15	MGTX
NUVL	0.69	0.14	0.63	-0.34	0.83	0.62	0.57	-0.53	-0.15		NUVL
	RVMD	AKRO	RNA	PTGX	STOK	QURE	RCKT	SLDB	MGTX	NUVL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RCKT	+ 0.9	RVMD
NUVL	+ 0.83	STOK
QURE	+ 0.79	STOK
RCKT	+ 0.79	QURE
STOK	+ 0.78	RVMD
QURE	+ 0.76	RVMD

High negative correlations

SLDB	- 0.63	STOK
MGTX	- 0.59	RCKT
RCKT	- 0.58	PTGX
NUVL	- 0.53	SLDB
SLDB	- 0.51	QURE
PTGX	- 0.51	RVMD

Risk-Adjusted Indicators

There is a big difference between Rhythm Stock performing well and Rhythm Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rhythm Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RVMD	1.75	(0.13)	0.00	(0.15)	0.00	0.00	4.37	(5.89)	11.35
AKRO	4.31	1.20	0.35	0.73	2.88	(5.92)	4.92	(5.64)	104.81
RNA	2.92	0.11	0.03	0.03	3.09	(3.63)	7.22	(4.79)	20.15
PTGX	2.79	0.45	0.20	(0.34)	2.47	(3.47)	3.48	(3.74)	50.66
STOK	3.45	(0.43)	0.00	(0.31)	0.00	0.00	7.03	(9.08)	20.29
QURE	3.89	(0.04)	0.00	(0.05)	0.00	0.00	7.02	(9.75)	26.87
RCKT	2.74	(0.36)	0.00	(0.32)	0.00	0.00	4.92	(6.06)	12.71
SLDB	5.04	0.36	0.06	0.14	4.90	(6.70)	11.61	(8.68)	41.64
MGTX	3.11	0.40	0.12	(1.59)	3.41	(3.51)	5.56	(5.58)	34.28
NUVL	2.06	(0.13)	0.00	(0.19)	0.00	0.00	3.54	(5.19)	12.24

Rhythm Pharmaceuticals Corporate Management

Jennifer Lee	Executive America	Profile
Yann Mazabraud	Executive International	Profile
Christopher German	Principal Controller	Profile
Sarah Ryan	Vice Marketing	Profile
Jim Flaherty	Senior Counsel	Profile
David Connolly	Head Communications	Profile
Joseph Shulman	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC